First Detection in Helicobacter suis of a Mutation Conferring Resistance to Clarithromycin in Helicobacter pylori: Case Report and Review of the Literature.

Helicobacter pylori and non-H. pylori Helicobacter (NHPH) are associated with gastritis, ulcer, and gastric neoplasia. Because of the impossibility to culture them, diagnosis remains based on microscopic examination and molecular analysis of biopsies. Owing to the lack of data concerning antibiotic resistance of NHPH, infected patients are usually treated using antibiotics, including clarithromycin. Herein, we describe, for the first time a human infection by Helicobacter suis harboring a mutation associated to clarithromycin resistance in H. pylori. Eradication was successful with a metronidazole-based treatment. This observation highlights the benefit to use genotypic detection of resistance to improve therapeutic management of NHPH infections.

[1]  T. Grossman,et al.  Resistance to Macrolide Antibiotics in Public Health Pathogens. , 2016, Cold Spring Harbor perspectives in medicine.

[2]  M. Hänninen,et al.  Characterization of Multiple Helicobacter bizzozeronii Isolates From a Finnish Patient With Severe Dyspeptic Symptoms and Chronic Active Gastritis , 2010, Helicobacter.

[3]  P. Vandamme,et al.  Isolation and characterization of Helicobacter suis sp. nov. from pig stomachs. , 2008, International journal of systematic and evolutionary microbiology.

[4]  F. Franceschi,et al.  Macrolide resistance from the ribosome perspective. , 2004, Current drug targets. Infectious disorders.

[5]  J. Solnick Clinical significance of Helicobacter species other than Helicobacter pylori. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.